-
N-[4-({3-butyl-1-[(2-fluorophenyl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl}methyl)phenyl]acetamide
-
ChemBase ID:
1775
-
Molecular Formular:
C25H26FN5O3
-
Molecular Mass:
463.5040432
-
Monoisotopic Mass:
463.20196794
-
SMILES and InChIs
SMILES:
O=C(C)Nc1ccc(cc1)Cc1nc2n(CCCC)c(=O)n(c(=O)c2[nH]1)Cc1ccccc1F
Canonical SMILES:
CCCCn1c2nc([nH]c2c(=O)n(c1=O)Cc1ccccc1F)Cc1ccc(cc1)NC(=O)C
InChI:
InChI=1S/C25H26FN5O3/c1-3-4-13-30-23-22(24(33)31(25(30)34)15-18-7-5-6-8-20(18)26)28-21(29-23)14-17-9-11-19(12-10-17)27-16(2)32/h5-12H,3-4,13-15H2,1-2H3,(H,27,32)(H,28,29)
InChIKey:
JHSHXKJSPVHPCJ-UHFFFAOYSA-N
-
Cite this record
CBID:1775 http://www.chembase.cn/molecule-1775.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
N-[4-({3-butyl-1-[(2-fluorophenyl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl}methyl)phenyl]acetamide
|
|
|
IUPAC Traditional name
|
N-[4-({3-butyl-1-[(2-fluorophenyl)methyl]-2,6-dioxo-7H-purin-8-yl}methyl)phenyl]acetamide
|
|
|
Synonyms
|
N-[4-[[3-Butyl-1-[(2-fluorophenyl)methyl]-2,3,6,9-tetrahydro-2,6-dioxo-1H-purin-8-yl]methyl]phenyl]acetamide
|
N-[4-[1-(2-Fluorobenzyl)-3-butyl-2,6-dixo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl]phenyl]acetamide
|
1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
7.857844
|
H Acceptors
|
4
|
H Donor
|
2
|
LogD (pH = 5.5)
|
3.6151993
|
LogD (pH = 7.4)
|
3.5051873
|
Log P
|
3.6168673
|
Molar Refractivity
|
127.6627 cm3
|
Polarizability
|
47.03535 Å3
|
Polar Surface Area
|
98.4 Å2
|
Rotatable Bonds
|
8
|
Lipinski's Rule of Five
|
true
|
Log P
|
3.63
|
LOG S
|
-4.22
|
Solubility (Water)
|
2.77e-02 g/l
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
DrugBank
TRC
Toronto Research Chemicals -
F588520
|
It is used for the preparation of amide-substituted xanthine derivatives as phosphoenolpyruvate carboxykinase inhibitors with gluconeogenesis modulating activity for treating type 2 diabetes. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Kawashima, Y., et al.: Chem. Pharm. Bull., 43, 1132 (1995)
- • Sun, Y., et al.: J. Biol. Chem., 277, 23301 (1995)
- • Foley, L., et al.: Bioorg. Med. Chem. Lett., 13, 3871 (1995)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent